IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Sylvia Caras <[log in to unmask]>
Reply To:
Date:
Mon, 10 Apr 2006 17:14:23 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (12 lines)
FDA has approved Daytrana, a once-daily skin patch for treating 
attention deficit hyperactivity disorder (ADHD) in children aged 6 to 
12 years. FDA calls the patch "an alternate route of administration" 
for the drug treatment. ADHD affects about three to seven percent of 
school-aged children in this country.

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01352.html



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2